Resveratrol Ameliorates Palmitate-Induced Inflammation in Skeletal Muscle Cells by Attenuating Oxidative Stress and JNK/NF-κB Pathway in a SIRT1-Independent Mechanism

Journal of Cellular Biochemistry

Volumn 118, Issue 9, 2017, Pages 2654-2663

  Sadeghi, Asie ^a   Seyyed Ebrahimi, Shadi Sadat ^a   Golestani, Abolfazl ^a   Meshkani, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

IL 6; INFLAMMATION; NF B; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RESVERATROL; SIRT1; SKELETAL MUSCLE CELLS; TNF

Indexed keywords

ACETYLCYSTEINE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTINOL; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MUSCLE PROTEIN; SIRT1 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION; SKELETAL MUSCLE CELL; UPREGULATION; ANIMAL; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; MAPK SIGNALING; METABOLISM; PATHOLOGY;

ANIMALS; CELL LINE; INFLAMMATION; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; NF-KAPPA B; OXIDATIVE STRESS; PALMITIC ACID; SIRTUIN 1; STILBENES;

EID: 85020009612     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25868     Document Type: Article

References (52)

1. Baeza-Raja B, Munoz-Canoves P. 2004. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: Role of interleukin-6. Mol Biol Cell 15:2013–2026.
2. Baker RG, Hayden MS, Ghosh S. 2011. NF-kappaB, inflammation, and metabolic disease. Cell Metab 13:11–22.
3. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA. 2003. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297–10303.
4. Coll T, Eyre E, Rodriguez-Calvo R, Palomer X, Sanchez RM, Merlos M, Laguna JC, Vazquez-Carrera M. 2008. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 283:11107–11116.
5. Corcoran MP, Lamon-Fava S, Fielding RA. 2007. Skeletal muscle lipid deposition and insulin resistance: Effect of dietary fatty acids and exercise. Am J Clin Nutr 85:662–677.
6. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. 2006. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: Role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol 291:H1694–H1699.
7. Cui Y, Wang Q, Yi X, Zhang X. 2016. Effects of fatty acids on CYP2A5 and nrf2 expression in mouse primary hepatocytes. Biochem Genet 54:29–40.
8. Dey D, Mukherjee M, Basu D, Datta M, Roy SS, Bandyopadhyay A, Bhattacharya S. 2005. Inhibition of insulin receptor gene expression and insulin signaling by fatty acid: Interplay of PKC isoforms therein. Cell Physiol Biochem 16:217–228.
9. Feng XT, Wang TZ, Leng J, Chen Y, Liu JB, Liu Y, Wang WJ. 2012. Palmitate contributes to insulin resistance through downregulation of the Src-mediated phosphorylation of Akt in C2C12 myotubes. Biosci Biotechnol Biochem 76:1356–1361.
10. Frost RA, Nystrom GJ, Lang CH. 2002. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. Am J Physiol Regul Integr Comp Physiol 283:R698–R709.
11. Frost RA, Nystrom GJ, Lang CH. 2003. Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: Role of the Jun NH2-terminal kinase. Am J Physiol Regul Integr Comp Physiol 285:R1153–R1164.
12. Ghanim H, Sia CL, Abuaysheh S, Korzeniewski K, Patnaik P, Marumganti A, Chaudhuri A, Dandona P. 2010. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab 95:E1–E8.
13. Ghanim H, Sia CL, Korzeniewski K, Lohano T, Abuaysheh S, Marumganti A, Chaudhuri A, Dandona P. 2011. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab 96:1409–1414.
14. Gonzales AM, Orlando RA. 2008. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond) 5:17.
15. Gorgani-Firuzjaee S, Bakhtiyari S, Golestani A, Meshkani R. 2012. Leukocyte antigen-related inhibition attenuates palmitate-induced insulin resistance in muscle cells. J Endocrinol 215:71–77.
16. Guo R, Li W, Liu B, Li S, Zhang B, Xu Y. 2014. Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro. Med Sci Monit Basic Res 20:82–92.
17. Hommelberg PP, Plat J, Langen RC, Schols AM, Mensink RP. 2009. Fatty acid-induced NF-kappaB activation and insulin resistance in skeletal muscle are chain length dependent. Am J Physiol Endocrinol Metab 296:E114–E120.
18. Horie M, Warabi E, Komine S, Oh S, Shoda J. 2015. Cytoprotective role of nrf2 in electrical pulse stimulated C2C12 myotube. PLoS ONE 10:e0144835.
19. Issuree PD, Pushparaj PN, Pervaiz S, Melendez AJ. 2009. Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities. FASEB J 23:2412–2424.
20. Jove M, Planavila A, Laguna JC, Vazquez-Carrera M. 2005. Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology 146:3087–3095.
21. Kesherwani V, Atif F, Yousuf S, Agrawal SK. 2013. Resveratrol protects spinal cord dorsal column from hypoxic injury by activating Nrf-2. Neuroscience 241:80–88.
22. Khodabandehloo H, Gorgani-Firuzjaee S, Panahi G, Meshkani R. 2016. Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction. Transl Res 167:228–256.
23. Kitada M, Kume S, Imaizumi N, Koya D. 2011. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60:634–643.
24. Klotz LO, Pellieux C, Briviba K, Pierlot C, Aubry JM, Sies H. 1999. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. Eur J Biochem 260:917–922.
25. Knobloch J, Wahl C, Feldmann M, Jungck D, Strauch J, Stoelben E, Koch A. 2014. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. Basic Clin Pharmacol Toxicol 114:202–209.
26. Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F. 2009. Activation of NF-kappaB by palmitate in endothelial cells: A key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol 29:1370–1375.
27. Manna SK, Mukhopadhyay A, Aggarwal BB. 2000. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164:6509–6519.
28. Meshkani R, Vakili S. 2016. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications. Clinica Chimica Acta 462:77–89.
29. Minagawa T, Okui T, Takahashi N, Nakajima T, Tabeta K, Murakami S, Yamazaki K. 2015. Resveratrol suppresses the inflammatory responses of human gingival epithelial cells in a SIRT1 independent manner. J Periodontal Res 50:586–593.
30. Pan W, Yu H, Huang S, Zhu P. 2016. Resveratrol protects against TNF-alpha-Induced injury in human umbilical endothelial cells through promoting sirtuin-1-Induced repression of NF-KB and p38 MAPK. PLoS ONE 11:e0147034.
31. Park GB, Choi Y, Kim YS, Lee HK, Kim D, Hur DY. 2014. ROS-mediated JNK/p38-MAPK activation regulates bax translocation in sorafenib-induced apoptosis of EBV-transformed B cells. Int J Oncol 44:977–985.
32. Park JM, Lee JS, Song JE, Sim YC, Ha SJ, Hong EK. 2015. Cytoprotective effect of hispidin against palmitate-induced lipotoxicity in C2C12 myotubes. Molecules 20:5456–5467.
33. Ren Z, Wang L, Cui J, Huoc Z, Xue J, Cui H, Mao Q, Yang R. 2013. Resveratrol inhibits NF-κB signaling through suppression of p65 and IkappaB kinase activities. Pharmazie 68:689–694.
34. Solinas G, Karin M. 2010. JNK1 and IKKbeta: Molecular links between obesity and metabolic dysfunction. FASEB J 24:2596–2611.
35. Storz P, Doppler H, Wernig A, Pfizenmaier K, Muller G. 1999. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Eur J Biochem 266:17–25.
36. Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q. 2007. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307–319.
37. Tak PP, Firestein GS. 2001. NF-kappaB: A key role in inflammatory diseases. J Clin Invest 107:7–11.
38. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen P. 2011. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612–622.
39. Tome-Carneiro J, Gonzalvez M, Larrosa M, Yanez-Gascon MJ, Garcia-Almagro FJ, Ruiz-Ros JA, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC. 2012. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am J Cardiol 110:356–363.
40. Tome-Carneiro J, Larrosa M, Yanez-Gascon MJ, Davalos A, Gil-Zamorano J, Gonzalvez M, Garcia-Almagro FJ, Ruiz Ros JA, Tomas-Barberan FA, Espin JC, Garcia-Conesa MT. 2013. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res 72:69–82.
41. Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, Starks T, Gurley C, Simpson P, McGehee RE, Jr., Kern PA, Peterson CA. 2009. Muscle inflammatory response and insulin resistance: Synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 296:E1300–E1310.
42. Wang Q, Cheng XL, Zhang DY, Gao XJ, Zhou L, Qin XY, Xie GY, Liu K, Qin Y, Liu BL, Qin MJ. 2013. Tectorigenin attenuates palmitate-induced endothelial insulin resistance via targeting ROS-associated inflammation and IRS-1 pathway. PLoS ONE 8:e66417.
43. Wang SL, Li Y, Wen Y, Chen YF, Na LX, Li ST, Sun CH. 2009. Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed Environ Sci 22:32–39.
44. Yeop Han C, Kargi AY, Omer M, Chan CK, Wabitsch M, O'Brien KD, Wight TN, Chait A. 2010. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: Dissociation of adipocyte hypertrophy from inflammation. Diabetes 59:386–396.
45. Yoshizaki T, Schenk S, Imamura T, Babendure JL, Sonoda N, Bae EJ, Oh DY, Lu M, Milne JC, Westphal C, Bandyopadhyay G, Olefsky JM. 2010. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 298:E419–E428.
46. Yuzefovych L, Wilson G, Rachek L. 2010. Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: Role of oxidative stress. Am J Physiol Endocrinol Metab 299:E1096–E1105.
47. Zagotta I, Dimova EY, Debatin KM, Wabitsch M, Kietzmann T, Fischer-Posovszky P. 2015. Obesity and inflammation: Reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue. Front Pharmacol 6:79.
48. Zagotta I, Dimova EY, Funcke JB, Wabitsch M, Kietzmann T, Fischer-Posovszky P. 2013. Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue. Oxid Med Cell Longev 2013:793525.
49. Zhang J, Gu JY, Chen ZS, Xing KC, Sun B. 2015. Astragalus polysaccharide suppresses palmitate-induced apoptosis in human cardiac myocytes: The role of Nrf1 and antioxidant response. Int J Clin Exp Pathol 8:2515–2524.
50. Zhang J, Wu W, Li D, Guo Y, Ding H. 2010. Overactivation of NF-kappaB impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells. Endocrine 37:157–166.
51. Zhong LM, Zong Y, Sun L, Guo JZ, Zhang W, He Y, Song R, Wang WM, Xiao CJ, Lu D. 2012. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLoS ONE 7:e32195.
52. Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H, Qiu J. 2011. Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS ONE 6:e27081.